Which makes you realize the nefariousness of inhibiting attempts at early treatment. Early treatment -> milder course of disease, less systemic ->better innate immune adaptation ->lower persistence of spike -> no long covid. Win win.
Which makes you realize the nefariousness of inhibiting attempts at early treatment. Early treatment -> milder course of disease, less systemic ->better innate immune adaptation ->lower persistence of spike -> no long covid. Win win.
Which makes you realize the nefariousness of inhibiting attempts at early treatment. Early treatment -> milder course of disease, less systemic ->better innate immune adaptation ->lower persistence of spike -> no long covid. Win win.
Lose Lose for Pharma. And there's the problem.